BMY

Bristol-Myers Squibb
D

BMY

Arincen68/100B

Bristol-Myers Squibb free cash flow 1989–2026

Bristol-Myers Squibb's free cash flow in Q3 FY2026, the three months to 30 September 2026, was 3.84B USD, down 36.0% on the same quarter a year before. Bristol-Myers Squibb's free cash flow over the last twelve months was 9.29B USD, down 39.3% on the twelve months before. In fiscal year 2025 it was 12.85B USD, down 7.9% on the year before.

Last updated 12 Nov 2026 · Next report 4 Feb 2027

Free cash flow

Free cash flow · +25.9% a year over 10 yearsFree cash flow margin

Growth

Fiscal yearPeriod endingFree cash flowGrowthFree cash flow marginOperating cash flowCapital expenditureFree cash flow per share
TTM30 Sept 20269.29B-39.32%18.56%10.65B-1.37B4.54
FY202531 Dec 202512.85B-7.87%26.65%14.16B-1.31B6.29
FY202431 Dec 202413.94B+10.20%28.87%15.19B-1.25B6.88
FY202331 Dec 202312.65B+5.88%28.11%13.86B-1.21B6.09
FY202231 Dec 202211.95B-21.57%25.88%13.07B-1.12B5.57
FY202131 Dec 202115.23B+14.55%32.84%16.21B-973.00M6.79
FY202031 Dec 202013.30B+80.35%31.28%14.05B-753.00M5.89
FY201931 Dec 20197.37B+20.59%28.20%8.21B-836.00M4.31
FY201831 Dec 20186.12B+44.91%27.10%7.07B-951.00M3.74
FY201731 Dec 20174.22B+128.97%20.31%5.28B-1.06B2.55
FY201631 Dec 20161.84B+43.42%9.49%3.06B-1.22B1.10
FY201531 Dec 20151.29B-50.99%7.76%2.11B-820.00M0.77
FY201431 Dec 20142.62B-12.83%16.51%3.15B-526.00M1.57
FY201331 Dec 20133.01B-52.95%18.36%3.55B-537.00M1.81
FY201231 Dec 20126.39B+42.92%36.28%6.94B-548.00M3.79
FY201131 Dec 20114.47B+9.98%21.06%4.84B-367.00M2.61
FY201031 Dec 20104.07B+21.95%20.87%4.49B-424.00M2.35
FY200931 Dec 20093.34B+20.57%17.73%4.07B-730.00M1.69
FY200831 Dec 20082.77B+19.74%13.43%3.71B-941.00M1.38
FY200731 Dec 20072.31B+79.07%11.94%3.15B-843.00M1.17
FY200631 Dec 20061.29B+20.79%7.20%2.08B-793.00M0.66
FY200531 Dec 20051.07B-54.88%5.56%1.84B-768.00M0.54
FY200431 Dec 20042.37B-6.15%12.21%3.18B-809.00M1.20
FY200331 Dec 20032.52B—12.07%3.51B-990.00M1.29
FY200231 Dec 2002-237.00M-105.41%-1.31%945.00M-1.18B-0.12
FY200131 Dec 20014.38B+7.78%22.55%5.40B-1.02B2.23
FY200031 Dec 20004.06B+15.59%22.30%4.65B-589.00M2.03
FY199931 Dec 19993.52B+17.40%17.38%4.22B-709.00M1.73
FY199831 Dec 19982.99B+75.19%16.37%3.78B-788.00M1.47
FY199731 Dec 19971.71B-16.23%10.23%2.48B-767.00M0.84
FY199631 Dec 19962.04B+2.72%13.54%2.64B-601.00M1.00
FY199531 Dec 19951.99B+14.93%14.43%2.50B-513.00M0.98
FY199431 Dec 19941.73B-14.03%14.42%2.30B-573.00M0.85
FY199331 Dec 19932.01B+45.55%17.61%2.58B-570.00M0.97
FY199231 Dec 19921.38B+14.42%12.38%2.03B-647.00M0.68
FY199131 Dec 19911.21B-2.58%10.82%1.84B-628.00M0.58
FY199031 Dec 19901.24B+95.12%12.03%1.75B-513.00M0.60
FY198931 Dec 1989635.00M—6.91%1.19B-555.00M0.31

Figures in USD. Free cash flow is operating cash flow less capital expenditure; owner earnings take off only the spending that keeps the business as it is, not the spending to grow it (an estimate by Financial Modeling Prep). Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

See also:Revenue,Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Stock buybacks,Cash flow

Common questions about Bristol-Myers Squibb's free cash flow

Source: Financial Modeling PrepVerified against SEC filings